Stealth BioTherapeutics Corp (NASDAQ:MITO) price is hovering higher on Wednesday, September 15, jumping 8.18% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $1.35, with intraday deals fluctuating between $1.15 and $1.36. The company’s 5Y monthly beta was ticking 2.02. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.58 and 52-week low of $1.06. The stock added 7.14% on its value in the past month.
Stealth BioTherapeutics Corp, which has a market valuation of $75.44 million, is expected to release its quarterly earnings report Aug 04, 2021 – Aug 09, 2021. Analysts tracking MITO have forecast the quarterly EPS to shrink by -0.02 per share this quarter, while the same analysts predict the annual EPS to hit -$0.07 for the year 2021 and up to -$0.07 for 2022.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give MITO a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 3 analysts have assigned MITO a recommendation rating as follows: 1 rate it as a Hold; 2 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Stealth BioTherapeutics Corp (MITO) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Overweight, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that MITO’s price is at present 14.45% off the SMA20 and 9.16% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 61.42, with weekly volatility standing at 8.30%. The indicator jumps to 7.14% when calculated based on the past 30 days. Stealth BioTherapeutics Corp (NASDAQ:MITO)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.09. Considering analysts have assigned the stock a price target range of $2.00-$4.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $3.00. Based on this estimate, we see that today’s price at last check is roughly -36.99% off the estimated low and -173.97% off the forecast high. Investors will no doubt be excited to see the share price fall to $3.00, which is the median consensus price, and at that level MITO would be -105.48% from recent price.
An analysis of the Stealth BioTherapeutics Corp (NASDAQ:MITO) stock in terms of its daily trading volume indicates that the 3-month average is 284.90K. However, this figure increases on the past 10-day timeline to an average of 0.36 million.
Current records show that the company has 55.88M in outstanding shares. The percentage share held by institutions stands at 10.20%. The stats also highlight that short interest as of May 27, 2021, stood at 0.79 million shares, which puts the short ratio at the time at 0.07. From this we can glean that short interest is 1.42% of company’s current outstanding shares. Notably, we see that shares short in May rose slightly given the previous month’s figure stood at 0.23 million. But the -9.70% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.